Skip to main content
Clinical Trials/TCTR20161213001
TCTR20161213001
Not yet recruiting
Phase 4

Comparison of the therapeutic effects of levetiracetam and sodium valproate on the containment of migraine headaches

Azad Islamic University0 sites52 target enrollmentDecember 13, 2016

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
52 patients suffering from migraine were evenly assigned to two groups of A (receivers of sodium valproate) and B (receivers of levetiracetam). Patients of both groups visited the hospital in three mo
Sponsor
Azad Islamic University
Enrollment
52
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 13, 2016
End Date
November 7, 2016
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria included: diagnosis of migraine based on the criteria of International Headache Society, 6 months of migraine attacks with auras, and no history of diseases that are compounded with headaches, consumption of prophylaxis for migraine in last 6 months.

Exclusion Criteria

  • drugs leading to headaches including Nitrogen compounds, oral contraceptive pills and alcohol. Patients who were not interested in the study, or the prescribed medicine was not effective in them, were discarded from the study

Outcomes

Primary Outcomes

Not specified

Similar Trials